Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Administration study of hematopoietic agents, diuretics, and anabolic steroids in healthy adult males
jRCT1071240052Recruiting
- Sponsor
- LSI Medience Corporation
- Start
- Aug 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of epoetin beta, epoetin alfa, spironolactone, potassium canrenoate, methyltestosterone and 1 more in Exposure to doping agents (6 arms), sponsored by LSI Medience Corporation. Primary endpoint: Effects of sample collection method. Started Aug 2024; status: recruiting.
02
Drugs
epoetin betaepoetin alfaspironolactonepotassium canrenoatemethyltestosterone
03
Conditions
Exposure to doping agents
Beyond the preview
Go deeper on jRCT1071240052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071240052.